399 related articles for article (PubMed ID: 22845491)
1. Sexual function, mood and menopause symptoms in Lithuanian postmenopausal women.
Jonusiene G; Zilaitiene B; Adomaitiene V; Aniuliene R; Bancroft J
Climacteric; 2013 Feb; 16(1):185-93. PubMed ID: 22845491
[TBL] [Abstract][Full Text] [Related]
2. Libido and orgasm in middle-aged woman.
González M; Viáfara G; Caba F; Molina T; Ortiz C
Maturitas; 2006 Jan; 53(1):1-10. PubMed ID: 16213679
[TBL] [Abstract][Full Text] [Related]
3. Low sexual function and its associated risk factors in pre- and postmenopausal women without clinically significant depression.
Verit FF; Verit A; Billurcu N
Maturitas; 2009 Sep; 64(1):38-42. PubMed ID: 19632073
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
[TBL] [Abstract][Full Text] [Related]
5. Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health.
Pace G; Silvestri V; Gualá L; Vicentini C
Menopause; 2009; 16(6):1188-92. PubMed ID: 19458558
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and psychological symptoms in Greek postmenopausal women: association with hormone therapy.
Koundi KL; Christodoulakos GE; Lambrinoudaki IV; Zervas IM; Spyropoulou A; Fexi P; Sakkas PN; Soldatos CR; Creatsas GC
Gynecol Endocrinol; 2006 Dec; 22(12):660-8. PubMed ID: 17162707
[TBL] [Abstract][Full Text] [Related]
7. Assessment of sexual function and related factors in mid-aged sexually active Spanish women with the six-item Female Sex Function Index.
Pérez-López FR; Fernández-Alonso AM; Trabalón-Pastor M; Vara C; Chedraui P;
Menopause; 2012 Nov; 19(11):1224-30. PubMed ID: 22781787
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Ziaei S; Moghasemi M; Faghihzadeh S
Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
[TBL] [Abstract][Full Text] [Related]
9. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
Gregersen N; Jensen PT; Giraldi AE
Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
[TBL] [Abstract][Full Text] [Related]
10. Sexual function, menopause and hormone replacement therapy (HRT).
González M; Viáfara G; Caba F; Molina E
Maturitas; 2004 Aug; 48(4):411-20. PubMed ID: 15283933
[TBL] [Abstract][Full Text] [Related]
11. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.
Cayan F; Dilek U; Pata O; Dilek S
J Sex Med; 2008 Jan; 5(1):132-8. PubMed ID: 17961145
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content.
Brooks NA; Wilcox G; Walker KZ; Ashton JF; Cox MB; Stojanovska L
Menopause; 2008; 15(6):1157-62. PubMed ID: 18784609
[TBL] [Abstract][Full Text] [Related]
14. Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status.
Travers C; O'Neill SM; King R; Battistutta D; Khoo SK
Climacteric; 2005 Mar; 8(1):56-62. PubMed ID: 15804732
[TBL] [Abstract][Full Text] [Related]
15. Assessment of sexuality among middle-aged women using the Female Sexual Function Index.
Chedraui P; Perez-Lopez FR; San Miguel G; Avila C
Climacteric; 2009 Jun; 12(3):213-21. PubMed ID: 19117186
[TBL] [Abstract][Full Text] [Related]
16. Sexual and psychological symptoms in the climacteric years.
Amore M; Di Donato P; Berti A; Palareti A; Chirico C; Papalini A; Zucchini S
Maturitas; 2007 Mar; 56(3):303-11. PubMed ID: 17084047
[TBL] [Abstract][Full Text] [Related]
17. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale.
Sierra B; Hidalgo LA; Chedraui PA
Maturitas; 2005 Jul; 51(3):236-45. PubMed ID: 15978967
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors.
Grigoriou V; Augoulea A; Armeni E; Rizos D; Alexandrou A; Dendrinos S; Panoulis K; Lambrinoudaki I
Gynecol Endocrinol; 2013 Feb; 29(2):125-8. PubMed ID: 22849709
[TBL] [Abstract][Full Text] [Related]
19. Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms.
Cheng RJ; Dupont C; Archer DF; Bao W; Racketa J; Constantine G; Pickar JH
Climacteric; 2013 Feb; 16(1):17-27. PubMed ID: 22646219
[TBL] [Abstract][Full Text] [Related]
20. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.
Diem SJ; Guthrie KA; Mitchell CM; Reed SD; Larson JC; Ensrud KE; LaCroix AZ
Menopause; 2018 Oct; 25(10):1086-1093. PubMed ID: 29738424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
